196 related articles for article (PubMed ID: 20111888)
1. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
[TBL] [Abstract][Full Text] [Related]
2. LYP, a bestatin dimethylaminoethyl ester, inhibited cancer angiogenesis both in vitro and in vivo.
Gao JJ; Xue X; Gao ZH; Cui SX; Cheng YN; Xu WF; Tang W; Qu XJ
Microvasc Res; 2011 Sep; 82(2):122-30. PubMed ID: 21664364
[TBL] [Abstract][Full Text] [Related]
3. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX
Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271
[TBL] [Abstract][Full Text] [Related]
4. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
Terauchi M; Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
BMC Cancer; 2007 Jul; 7():140. PubMed ID: 17655775
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.
Hossain A; Heron D; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Wang S; Bhattacharjee PS
Exp Eye Res; 2016 Aug; 149():100-106. PubMed ID: 27344955
[TBL] [Abstract][Full Text] [Related]
7.
Kis A; Dénes N; Szabó JP; Arató V; Beke L; Matolay O; Enyedi KN; Méhes G; Mező G; Bai P; Kertész I; Trencsényi G
Biomed Res Int; 2021; 2021():6642973. PubMed ID: 33778075
[TBL] [Abstract][Full Text] [Related]
8. LYP3, a new bestatin derivative for aminopeptidase N inhibition.
Luan Y; Ma C; Sui Z; Wang X; Feng J; Liu N; Jing F; Wang Y; Li M; Fang H; Xu W
Med Chem; 2011 Jan; 7(1):32-6. PubMed ID: 21235517
[TBL] [Abstract][Full Text] [Related]
9. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13).
Cui SX; Zhang HL; Xu WF; Qu XJ
Eur J Pharmacol; 2014 Jul; 734():50-9. PubMed ID: 24726845
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
Toshiyama R; Konno M; Eguchi H; Takemoto H; Noda T; Asai A; Koseki J; Haraguchi N; Ueda Y; Matsushita K; Asukai K; Ohashi T; Iwagami Y; Yamada D; Sakai D; Asaoka T; Kudo T; Kawamoto K; Gotoh K; Kobayashi S; Satoh T; Doki Y; Nishiyama N; Mori M; Ishii H
Oncogene; 2019 Jan; 38(2):244-260. PubMed ID: 30089817
[TBL] [Abstract][Full Text] [Related]
11. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
[TBL] [Abstract][Full Text] [Related]
13. Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells.
Mishima Y; Terui Y; Sugimura N; Matsumoto-Mishima Y; Rokudai A; Kuniyoshi R; Hatake K
Cancer Sci; 2007 Mar; 98(3):364-72. PubMed ID: 17270026
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD13/aminopeptidase N and CD10/neutral endopeptidase on cultured human keratinocytes.
Gabrilovac J; Cupić B; Breljak D; Zekusić M; Boranić M
Immunol Lett; 2004 Jan; 91(1):39-47. PubMed ID: 14757368
[TBL] [Abstract][Full Text] [Related]
15. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885
[TBL] [Abstract][Full Text] [Related]
16. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin.
Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Park HJ; Shim BS; Choi SH; Kwon HJ
Chem Biol; 2003 Aug; 10(8):695-704. PubMed ID: 12954328
[TBL] [Abstract][Full Text] [Related]
17. Development of a Bestatin-SAHA Hybrid with Dual Inhibitory Activity against APN and HDAC.
Cao J; Zhao W; Zhao C; Liu Q; Li S; Zhang G; Chou CJ; Zhang Y
Molecules; 2020 Oct; 25(21):. PubMed ID: 33126591
[TBL] [Abstract][Full Text] [Related]
18. Preliminary detection of the anti‑tumour activity of indoline‑2,3‑dione derivative DH‑12a targeting aminopeptidase N.
Cui DX; Wang XJ; Zhang XR; Zhao TK; Guo XX; Liu SM; Wang B; Ma WQ; Gao ZQ
Mol Med Rep; 2014 Nov; 10(5):2681-8. PubMed ID: 25216231
[TBL] [Abstract][Full Text] [Related]
19. Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells.
Mishima Y; Matsumoto-Mishima Y; Terui Y; Katsuyama M; Yamada M; Mori M; Ishizaka Y; Ikeda K; Watanabe J; Mizunuma N; Hayasawa H; Hatake K
J Natl Cancer Inst; 2002 Jul; 94(13):1020-8. PubMed ID: 12096087
[TBL] [Abstract][Full Text] [Related]
20. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
Imamura N; Kimura A
Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
